Connect with us


“The best years are ahead of me”: How CBD is helping this former Paralympian get back on track



Will Smith competed at the 2014 Commonwealth Games

A Paralympian who competed at the 2014 Commonwealth Games in Glasgow aims to return to professional wheelchair racing in 2021 – and he says CBD is helping him get there.

Will Smith, 25, from Northallerton, suffers from Spina Bifida, a lifelong spinal condition which means he has no use of his lower limbs.

At the age of eight years old, he competed for the first time in wheelchair racing athletics and has since represented Team GB, becoming a decorated Paralympian who was tipped to follow in the footsteps of his mentor, six-time gold medallist David Weir CBE.

Following a successful stint competing for the national team, both at a junior and senior level, Will side-lined his competitive wheelchair athletics to study law at university.

“I partly decided to go [to University] because I was always interested in the academic side of things while I was training and competing, but I also wanted to move down to London, because that’s where my training base was,” Will tells Cannabis Health.

“I managed to balance the training and studying at the same time, but as I was really enjoying the degree I was studying, I thought I’d like to really make a go of it.

“The training dropped off a little bit so I could focus on my degree and now I’ve graduated and landed my first job in the legal sector, I’m starting to increase my training again.”

Now working in the trademark department at the UK Intellectual Property Office, Will is undertaking an increasingly tough training schedule as he builds towards competitive racing again in 2021.

He has been using a CBD to combat the aches and pains induced by a gruelling training routine, as he targets a return to competitive racing.

“I plan to enter some domestic competitions by the middle of next year and then hopefully to kick on into the winter. I see the spring of the year after that as a benchmark to properly get back into the sport,” Will adds.

Former Paralympian, Will Smith.


While working to get his fitness levels back to competitive standards, Will has become reacquainted with the challenge of injuries and niggles that come with the territory of wheelchair racing.

Wrist injuries are common, as the sport requires a demanding clenched-fist technique on the push rims of the wheelchair.

Finding that these injuries and strains had a negative effect on both his training and his concentration in his day job, Will started using a pain-relieving CBD topical gel, applying it to his wrists, back of his neck and upper shoulder area before and after sessions.

He instantly noticed a benefit to his training capacity, completing longer sessions and recovering from his training at a quicker pace than usual.

“With wheelchair racing, you tend to see athletes really struggle with wrist injuries and shoulder impairments,” Will explains.

“Our bodies aren’t designed to do what we do in terms of the training and the force that we need to generate through these parts of the body.

“I’ve previously had wrist and shoulder injuries, so I would use it initially as a preventative measure before a session. I would put it onto the wrist areas and found that I could train at a higher intensity for a little bit longer without necessarily feeling those common pains that I usually get.”

He adds: “I’d also use it for niggles that I felt when the day’s finished to help with the recovery. With the training that’s required for elite athletes, time is extremely precious and valuable. The ability to use it as many times as you need without the need for a physio is something I’ve really benefited from.”

CBD treatments for athletes are not uncommon in the marketplace since the World Anti-Doping Agency (WADA) removed the anti-inflammatory cannabis compound from its prohibited substances list in 2018.

Looking back to this time, Will remembers a stigma surrounding the supplement and a hesitation among the sporting community.

“There was definitely a kind of hesitancy,” he recalls.

“And with British Athletics being my governing body, they were obviously really conscious and tight on what you put into your body. I think now, as the market grows and expands, people are becoming more aware of the legitimate high-quality products on the market and some of the real benefits that people can enjoy from it.”

Despite growing awareness of the supplement and a widening choice of products, it was difficult for Will to find a compliant solution. Many CBD brands claimed to have products with low-THC without certification. As professional athletes are subject to THC testing, making many of these options were unusable for him.

In the end, Will settled on the brand, Biosportart, which has undertaken third-party certification from the Banned Substances Control Group (BSCG), confirming their products contain absolutely no THC, making it a safe option for elite performers like Will.

“Before I found this gel, there just were not quality products out there with the third-party verification that you could trust,” Will says.

“WADA removed CBD from the prohibited substance list, but they are very clear that any other residue of the cannabis plant, not just THC, is illegal.”

Will’s targeted comeback for 2021-22 will be welcome after a frustrating year in light of the COVID-19 climate. At 25, he feels confident that he is yet to achieve his athletic peak. There are still records to be beaten, as he still seeks to fulfil and surpass expectations that he will be the next David Weir of the sport.

“2020 has been a pretty trying time for everyone and of course I’m just thankful that I have my health, but like most people, quietly hoping that things get back to normality soon. Ultimately, I’d like to get back to the level I was at and of course, exceed it,” he says.

“I think the beauty of wheelchair racing is that it’s a real endurance and power-based sport, so we find that the guys who compete at the top level tend to peak in their late 20s or early 30s.

“I’m lucky that at my age, I’m still considered to have my best years ahead of me.”


New research refutes ‘gateway drug’ fears over cannabis legalisation

Young adults consumed less alcohol, cigarettes and other substances following cannabis legalisation in Washington State.



New research refutes cannabis as 'gateway drug' theory
Adult-use cannabis has been legal in Washington State since 2012

Young adults consume less alcohol, cigarettes and other substances following cannabis legalisation, according to a new study.

A paper published earlier this month by researchers at the University of Washington, found that young people consumed less alcohol, nicotine, and non-prescribed pain medication, after cannabis was legalised for adult-use. 

Researchers assessed trends in alcohol, nicotine, and non-prescribed pain reliever use among a cohort of over 12,500 young adults (ages 18 to 25) in Washington State following legalisation in 2012.

Contrary to concerns about the detrimental effects on wider society, according to the study, “the implementation of legalised non-medical cannabis coincided with decreases in alcohol and cigarette use and pain reliever misuse.”

The findings show that prevalence of alcohol use, heavy episodic drinking and cigarette use in the past month, as well as prevalence of past-year pain reliever misuse decreased. 

While the prevalence of substance use other than cannabis was “higher among occasional and frequent cannabis users compared to cannabis non-users”, associations between cannabis and pain reliever misuse and heavy episodic drinking “weakened over time”. 

However the team did find that the prevalence of past-month e-cigarette use had increased post-legalisation.

They concluded: “Our findings add to evidence that the legalisation of non-medical cannabis has not led to dramatic increases in the use of alcohol, cigarettes, and non-prescribed opioids.

“The findings indicate that the most critical public health concerns surrounding cannabis legalisation and the evolution of legalised cannabis markets may be specific to cannabis use and related consequences.”

Commenting on the study’s findings, NORML’s Deputy Director Paul Armentano said: “Real-world data from legalisation states disputes longstanding claims that cannabis is some sort of ‘gateway’ substance. In fact, in many instances, cannabis regulation is associated with the decreased use of other substances, including many prescription medications.”

Cannabis legalisation in the UK

Cannabis legalisation is a hot topic in the UK at the moment, following London Mayor Sadiq Khan’s fact-finding trip to LA last week. He subsequently announced that he would be launching a review panel to explore the possibility of decriminalisation in the UK. 

This has sparked debate among politicians, media personalities and the general public alike. 

While Home Secretary Priti Patel shared her thoughts that cannabis can “ruin communities, tear apart families and destroy lives”, Policing Minister Kit Malthouse described it as an “entry level drug”. 

And even Labour refused to get behind Khan, saying the party “does not support changing the law on drugs.”

But recent polling suggests the politicians may be out of touch with the public. YouGov polls show that more than half of Londoners support the mayor’s proposals. 

Meanwhile a poll last year revealed that 52 per cent of the population either ‘strongly supported’ or  ‘tended to support’ legalisation. 


Home » News » “The best years are ahead of me”: How CBD is helping this former Paralympian get back on track

Continue Reading


Medical cannabis in the mainstream – the top headlines this week

Get up to date on the week’s headlines.



Medical cannabis in the mainstream - the top headlines this week

This week the media has been dominated with responses to Sadiq Khan’s controversial fact-finding mission to LA and plans for cannabis decriminalisation.

Although stories of police raids and cannabis farm busts continue to make up the majority of major cannabis headlines, the mainstream media is increasingly covering new developments in the cannabis space, from policy to patient stories.

Over the past few days, MPs have been responding to Sadiq Khan’s controversial trip to LA cultivators and dispensaries, while the Daily Express reported on a new study about a cannabis-based product aiming to treat chronic pain. Here are the week’s five top cannabis headlines not to miss.

The medical cannabis clinic banner

New study into cannabis for chronic pain

Daily Express spoke to the managing director of LVL Health, Tony Samios, about the company’s feasibility study which explores the effects of a cannabis-based product for chronic pain. The study will use cannabis flower in pre-filled cartridges and aims to build the data and evidence needed to improve patient access on the NHS.

Samios told the Express that the study is set to be a “game-changer in bridging the gap between evidence and making change using a rigorous scientific approach” providing “reliable data that is essentially missing”.

Sadiq Khan’s time would be “better spent focusing on knife and drug crime”, says Patel

Priti Patel made her thoughts on Sadiq Khan’s plan to consider cannabis legalisation in London clear in a Twitter post last week.

“Sadiq Khan’s time would be better spent focusing on knife and drug crime in London. The Mayor has no powers to legalise drugs. They ruin communities, tear apart families and destroy lives,” Patel said in the Tweet.

Her rebuke comes after Sadiq Khan’s recent trip to the US which included a fact-finding mission to LA to understand more about an international evidence-based approach to reducing drug-related harm in the capital. The London mayor also announced the launch of a new London Drugs Commission.

Policing Minister Kit Malthouse expressed a similar view to Patel. Last week he told The Sun: “I find it baffling that just last week, the Mayor of London thought it appropriate to stage a photoshoot in a cannabis farm in LA, to reiterate his support for the legalisation of this entry level drug. I profoundly wish he would focus on knife crime and violence taking place in the capital instead.”

Khan initially made his plans clear last year prior to his re-election, saying that he would consider decriminalising cannabis in the capital if he were to be voted in as mayor for a second term.

The Labour party’s response to Khan’s cannabis plan

The likes of Huffington Post, Daily Mail and iNews reported on the Labour party’s response to Sadiq Khan’s plans for cannabis law reform last week.

The party’s stance was made clear in a statement that stated: “Labour does not support changing the law on drugs. Drugs policy is not devolved to mayors and under Labour would continue to be set by national Government.”

HuffPost UK reported that a number of shadow cabinet members were “furious” at Khan’s comments, including Yvette Cooper. “Yvette is furious about it,” a Labour source told HuffPost UK. “People are just rolling their eyes because it definitely is not the official party line.”

Although it goes against his party’s official stance, Khan’s plan reflects data gathered by YouGov which has found that the majority of UK citizens are in support of cannabis legalisation.

Another source told the online outlet: “Sadiq has positioned himself as a progressive mayor on the side of the public prepared to take on the tough questions to genuinely tackle crime rather than pointless posturing that isn’t even popular anyway.”

Meanwhile, iNews reported that Labour MPs “let rip” in a private WhatsApp group. “This is going to go down like a bucket of cold sick in my bit of the suburbs just now… Crime up, police numbers still way below where people think they should be, so Labour is going to have a chat about drugs… Inspired,” said Gareth Thomas, the Shadow International Trade minister.

Not all Labour MPs have responded negatively, however. The Daily Mail reported on Shadow Cabinet minister Ed Miliband’s response to Khan’s plans. Although he highlighted that Khan did not reflect the Party’s position, he said Labour “welcome[s] Sadiq looking at these issues because this debate should carry on”.

“Cannabis ruins lives and legalising it won’t help”

In response to Sadiq Khan’s US visit, journalist and campaigner Louise Perry offered her opinion in an article for the London Evening Standard. While she said she would be “happy” to see possession of small amounts of cannabis made legal, but added that legalising the cannabis industry is “another matter entirely”.

The article is unlikely to sit well with cannabis campaigners and advocates thanks to its comparison between cannabis and tobacco, a focus on the dangers of psychosis and the lack of attention given to studies showing the positive effects of cannabis on health and wellbeing.

“Industries employ lobbyists to disguise the harmful effects of the products they sell,” Perry writes. “This has happened many times before.

“By the early 50s, the scientific evidence was clear: tobacco was killing people. And yet it would be 20 years until warning signs appeared on the side of cigarette packets sold in the UK. This tardiness was the result of lobbying by the tobacco industry, which opposed health authorities every step of the way.”

Patient faces dispute with council over housing

A man living in Norwich who holds a private cannabis prescription says he is facing difficulties finding a new place to live after being told by the city council to disclose his indoor cannabis use to landlords.

As reported by Norwich Evening News, Danny Wilson is prescribed legal cannabis by TMCC Medical Clinic for chronic pain, ADHD and anxiety. Wilson – who is currently on universal credit and personal independence payments due to his condition – pays between £700 and £1,000 per month for his medication.

Mr Wilson said: “I’ve repeatedly told them forcing me to go around approaching landlords and agents this way is causing me trauma but they ignored me.”

Despite never having being in prison, the city council offered him a place at House of Genesis, a rehoming initiative for ex-offenders.

Home » News » “The best years are ahead of me”: How CBD is helping this former Paralympian get back on track

Continue Reading


Medical cannabis in the mainstream – the UK’s top stories

All your cannabis news in one place



There has been a mix of cannabis-related stories in the media over the past week. In case you missed them, we’ve compiled some of the headlines.

This week, news outlets such as The Guardian and The Telegraph have reported on UK medical cannabis labs, cannabis use for fibromyalgia and a rise in drug-driving cases amongst medical consumers.

Inside one of the UK’s first medical cannabis labs

The Guardian’s Julia Kollewe visited a growing lab owned by Celadon Pharmaceuticals, one of the first cultivation sites to be granted a home office licence to grow high-THC medical cannabis in the UK. The site is based in the West Midlands and grows cannabis predominantly for chronic pain. It is one of the only cannabis cultivators in the country to use an indoor lab rather than greenhouses.

According to The Guardian, Celadon is planning to ramp up production, aiming to grow 10 to 15 tonnes a year and supply up to 50,000 patients. At full capacity, the lab could generate £90m in annual revenues.

Founder James Short said: “I speak to patients on a regular basis who can’t work and are in terrible pain each day, that don’t want to be on opioids. Some are having to pay hundreds of pounds each month for medicinal cannabis. It really does work.”

US research programme studies cannabinoids in ovarian cancer

“Massive injustice” – medical cannabis patients facing driving offences

In a less positive story, The Telegraph reported that medicinal cannabis patients are increasingly being prosecuted for drug driving with arrests reportedly doubling in the last four years.

Those taking cannabis may face a positive result in police roadside testing up to 72 hours after taking the drug. Although studies have shown driving capabilities are not impaired after this length of time, patients still face prosecution.

Since 2016, arrests linked with drug driving have increased by 140 per cent, according to police figures obtained by The Telegraph.

But while medical cannabis patients are at risk of arrest, those taking opiate-based prescription drugs are permitted to drive even if they are over the lawful limit, provided they follow their doctor’s advice.

The Telegraph spoke to one patient, David Dancy, who was being prosecuted for drug driving despite the fact he had taken his prescription 12 hours prior to getting in his car. The 33-year-old said the prosecution is “a massive injustice”.

Fibromyalgia and arthritis patient on how cannabis changed her life

Andrea Wright, a medical cannabis patient from Bristol, spoke to The Guardian about her ongoing battle with psoriatic arthritis and fibromyalgia. The 39-year-old was diagnosed in 2016, suffering from constant pain and severe lack of sleep. She eventually was forced to leave her job due to her ill health.

“I had to stop work because the pain was too much. It’s been very depressing; I really enjoyed my job. I tried so many different therapies and managed to get my arthritis under control but for fibromyalgia, there isn’t anything, no magical pill,” Wright told The Guardian.

After trying medical cannabis as part of a study run by LVL Health, she found she was able to get her first “proper night’s sleep” since 2012. She is now back at work and now aiming to reduce her reliance on opioid painkillers.

300 campaigners march through streets of Cardiff

Campaigners calling for the legalisation of cannabis in the UK marched through Cardiff city centre this weekend, WalesOnline reported on Saturday (7 May).  This was the first protest to take place in Wales since before the pandemic.

The march was organised by Terry Wakefield, who has been involved in cannabis campaigning since 1999. She told WalesOnline that the stigma surrounding cannabis was pushing the trade further underground.

“Cannabis is my medicine. I suffer complex PTSD and this march might sometimes be the only time I’m outside,” she said. “If I was in a position where I could go to my GP and ask for a prescription I would do.

“If we are able to consume cannabis in the UK then we should have a right to grow our own. The more this stays illegal the more it will be pushed underground and the more gangs and slaves in Britain.”

Home » News » “The best years are ahead of me”: How CBD is helping this former Paralympian get back on track

Continue Reading